img

Global Platinum based Cancer Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Platinum based Cancer Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Platinum-based antineoplastic drugs (informally called platins) are chemotherapeutic agents used to treat cancer. They are coordination complexes of platinum. These drugs are used to treat almost half of people receiving chemotherapy for cancer. In this form of chemotherapy, popular drugs include cisplatin, oxaliplatin, and carboplatin, but several have been proposed or are under development.
Platinum based Cancer Drug report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Platinum based Cancer Drug market is projected to reach US$ 1862.2 million in 2034, increasing from US$ 1541.9 million in 2022, with the CAGR of 2.7% during the period of 2024 to 2034. Demand from Colorectal Cancer and Ovarian Cancer are the major drivers for the industry.
The classification of platinum based cancer drug includes cisplatin, oxaliplatin, carboplatin and other types. The proportion of oxaliplatin is about 71%.
Platinum based cancer drug is widely used for colorectal cancer, ovarian cancer, lung cancer and other cancer. The most proportion of platinum based cancer drug is for colorectal cancer, and the proportion is about 62%.
Asia-Pacific is the largest market, with a sales market share nearly 53%. Following Asia-Pacific, Europe is the second largest sales place with the sales market share of 17%.
Market competition is intense. Sanofi, Hengrui Medicine, ASK Pharma, Yi Bai Pharmaceutical, Qilu Pharmaceutical and Teva, etc. are the leaders of the industry, with about 42% market shares.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Platinum based Cancer Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi
Hengrui Medicine
ASK Pharma
Yi Bai Pharmaceutical
Qilu Pharmaceutical
Teva
Pfizer
Dr Reddy's Laboratories
Mylan
Sun Pharma
Novartis
Debiopharm
Accord Healthcare
SK Chemicals
Segment by Type
Cisplatin
Oxaliplatin
Carboplatin
Others

Segment by Application


Colorectal Cancer
Ovarian Cancer
Lung Cancer
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Platinum based Cancer Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Platinum based Cancer Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Platinum based Cancer Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Platinum based Cancer Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Platinum based Cancer Drug introduction, etc. Platinum based Cancer Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Platinum based Cancer Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Platinum based Cancer Drug Market Overview
1.1 Platinum based Cancer Drug Product Overview
1.2 Platinum based Cancer Drug Market Segment by Type
1.2.1 Cisplatin
1.2.2 Oxaliplatin
1.2.3 Carboplatin
1.2.4 Others
1.3 Global Platinum based Cancer Drug Market Size by Type
1.3.1 Global Platinum based Cancer Drug Market Size Overview by Type (2018-2034)
1.3.2 Global Platinum based Cancer Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Platinum based Cancer Drug Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Platinum based Cancer Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Platinum based Cancer Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Platinum based Cancer Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Platinum based Cancer Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Platinum based Cancer Drug Sales Breakdown by Type (2018-2024)
2 Global Platinum based Cancer Drug Market Competition by Company
2.1 Global Top Players by Platinum based Cancer Drug Sales (2018-2024)
2.2 Global Top Players by Platinum based Cancer Drug Revenue (2018-2024)
2.3 Global Top Players by Platinum based Cancer Drug Price (2018-2024)
2.4 Global Top Manufacturers Platinum based Cancer Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Platinum based Cancer Drug Market Competitive Situation and Trends
2.5.1 Platinum based Cancer Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Platinum based Cancer Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Platinum based Cancer Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Platinum based Cancer Drug Market
2.8 Key Manufacturers Platinum based Cancer Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Platinum based Cancer Drug Status and Outlook by Region
3.1 Global Platinum based Cancer Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Platinum based Cancer Drug Historic Market Size by Region
3.2.1 Global Platinum based Cancer Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Platinum based Cancer Drug Sales in Value by Region (2018-2024)
3.2.3 Global Platinum based Cancer Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Platinum based Cancer Drug Forecasted Market Size by Region
3.3.1 Global Platinum based Cancer Drug Sales in Volume by Region (2024-2034)
3.3.2 Global Platinum based Cancer Drug Sales in Value by Region (2024-2034)
3.3.3 Global Platinum based Cancer Drug Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Platinum based Cancer Drug by Application
4.1 Platinum based Cancer Drug Market Segment by Application
4.1.1 Colorectal Cancer
4.1.2 Ovarian Cancer
4.1.3 Lung Cancer
4.1.4 Others
4.2 Global Platinum based Cancer Drug Market Size by Application
4.2.1 Global Platinum based Cancer Drug Market Size Overview by Application (2018-2034)
4.2.2 Global Platinum based Cancer Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Platinum based Cancer Drug Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Platinum based Cancer Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Platinum based Cancer Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Platinum based Cancer Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Platinum based Cancer Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Platinum based Cancer Drug Sales Breakdown by Application (2018-2024)
5 North America Platinum based Cancer Drug by Country
5.1 North America Platinum based Cancer Drug Historic Market Size by Country
5.1.1 North America Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Platinum based Cancer Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Platinum based Cancer Drug Sales in Value by Country (2018-2024)
5.2 North America Platinum based Cancer Drug Forecasted Market Size by Country
5.2.1 North America Platinum based Cancer Drug Sales in Volume by Country (2024-2034)
5.2.2 North America Platinum based Cancer Drug Sales in Value by Country (2024-2034)
6 Europe Platinum based Cancer Drug by Country
6.1 Europe Platinum based Cancer Drug Historic Market Size by Country
6.1.1 Europe Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Platinum based Cancer Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Platinum based Cancer Drug Sales in Value by Country (2018-2024)
6.2 Europe Platinum based Cancer Drug Forecasted Market Size by Country
6.2.1 Europe Platinum based Cancer Drug Sales in Volume by Country (2024-2034)
6.2.2 Europe Platinum based Cancer Drug Sales in Value by Country (2024-2034)
7 Asia-Pacific Platinum based Cancer Drug by Region
7.1 Asia-Pacific Platinum based Cancer Drug Historic Market Size by Region
7.1.1 Asia-Pacific Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Platinum based Cancer Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Platinum based Cancer Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Platinum based Cancer Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Platinum based Cancer Drug Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Platinum based Cancer Drug Sales in Value by Region (2024-2034)
8 Latin America Platinum based Cancer Drug by Country
8.1 Latin America Platinum based Cancer Drug Historic Market Size by Country
8.1.1 Latin America Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Platinum based Cancer Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Platinum based Cancer Drug Sales in Value by Country (2018-2024)
8.2 Latin America Platinum based Cancer Drug Forecasted Market Size by Country
8.2.1 Latin America Platinum based Cancer Drug Sales in Volume by Country (2024-2034)
8.2.2 Latin America Platinum based Cancer Drug Sales in Value by Country (2024-2034)
9 Middle East and Africa Platinum based Cancer Drug by Country
9.1 Middle East and Africa Platinum based Cancer Drug Historic Market Size by Country
9.1.1 Middle East and Africa Platinum based Cancer Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Platinum based Cancer Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Platinum based Cancer Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Platinum based Cancer Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Platinum based Cancer Drug Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Platinum based Cancer Drug Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sanofi
10.1.1 Sanofi Company Information
10.1.2 Sanofi Introduction and Business Overview
10.1.3 Sanofi Platinum based Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi Platinum based Cancer Drug Products Offered
10.1.5 Sanofi Recent Development
10.2 Hengrui Medicine
10.2.1 Hengrui Medicine Company Information
10.2.2 Hengrui Medicine Introduction and Business Overview
10.2.3 Hengrui Medicine Platinum based Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Hengrui Medicine Platinum based Cancer Drug Products Offered
10.2.5 Hengrui Medicine Recent Development
10.3 ASK Pharma
10.3.1 ASK Pharma Company Information
10.3.2 ASK Pharma Introduction and Business Overview
10.3.3 ASK Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 ASK Pharma Platinum based Cancer Drug Products Offered
10.3.5 ASK Pharma Recent Development
10.4 Yi Bai Pharmaceutical
10.4.1 Yi Bai Pharmaceutical Company Information
10.4.2 Yi Bai Pharmaceutical Introduction and Business Overview
10.4.3 Yi Bai Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Yi Bai Pharmaceutical Platinum based Cancer Drug Products Offered
10.4.5 Yi Bai Pharmaceutical Recent Development
10.5 Qilu Pharmaceutical
10.5.1 Qilu Pharmaceutical Company Information
10.5.2 Qilu Pharmaceutical Introduction and Business Overview
10.5.3 Qilu Pharmaceutical Platinum based Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Qilu Pharmaceutical Platinum based Cancer Drug Products Offered
10.5.5 Qilu Pharmaceutical Recent Development
10.6 Teva
10.6.1 Teva Company Information
10.6.2 Teva Introduction and Business Overview
10.6.3 Teva Platinum based Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Teva Platinum based Cancer Drug Products Offered
10.6.5 Teva Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Information
10.7.2 Pfizer Introduction and Business Overview
10.7.3 Pfizer Platinum based Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Pfizer Platinum based Cancer Drug Products Offered
10.7.5 Pfizer Recent Development
10.8 Dr Reddy's Laboratories
10.8.1 Dr Reddy's Laboratories Company Information
10.8.2 Dr Reddy's Laboratories Introduction and Business Overview
10.8.3 Dr Reddy's Laboratories Platinum based Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Dr Reddy's Laboratories Platinum based Cancer Drug Products Offered
10.8.5 Dr Reddy's Laboratories Recent Development
10.9 Mylan
10.9.1 Mylan Company Information
10.9.2 Mylan Introduction and Business Overview
10.9.3 Mylan Platinum based Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Mylan Platinum based Cancer Drug Products Offered
10.9.5 Mylan Recent Development
10.10 Sun Pharma
10.10.1 Sun Pharma Company Information
10.10.2 Sun Pharma Introduction and Business Overview
10.10.3 Sun Pharma Platinum based Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Sun Pharma Platinum based Cancer Drug Products Offered
10.10.5 Sun Pharma Recent Development
10.11 Novartis
10.11.1 Novartis Company Information
10.11.2 Novartis Introduction and Business Overview
10.11.3 Novartis Platinum based Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Novartis Platinum based Cancer Drug Products Offered
10.11.5 Novartis Recent Development
10.12 Debiopharm
10.12.1 Debiopharm Company Information
10.12.2 Debiopharm Introduction and Business Overview
10.12.3 Debiopharm Platinum based Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Debiopharm Platinum based Cancer Drug Products Offered
10.12.5 Debiopharm Recent Development
10.13 Accord Healthcare
10.13.1 Accord Healthcare Company Information
10.13.2 Accord Healthcare Introduction and Business Overview
10.13.3 Accord Healthcare Platinum based Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Accord Healthcare Platinum based Cancer Drug Products Offered
10.13.5 Accord Healthcare Recent Development
10.14 SK Chemicals
10.14.1 SK Chemicals Company Information
10.14.2 SK Chemicals Introduction and Business Overview
10.14.3 SK Chemicals Platinum based Cancer Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 SK Chemicals Platinum based Cancer Drug Products Offered
10.14.5 SK Chemicals Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Platinum based Cancer Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Platinum based Cancer Drug Industrial Chain Analysis
11.4 Platinum based Cancer Drug Market Dynamics
11.4.1 Platinum based Cancer Drug Industry Trends
11.4.2 Platinum based Cancer Drug Market Drivers
11.4.3 Platinum based Cancer Drug Market Challenges
11.4.4 Platinum based Cancer Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Platinum based Cancer Drug Distributors
12.3 Platinum based Cancer Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Cisplatin
Table 2. Major Company of Oxaliplatin
Table 3. Major Company of Carboplatin
Table 4. Major Company of Others
Table 5. Global Platinum based Cancer Drug Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Platinum based Cancer Drug Sales by Type (2018-2024) & (K Units)
Table 7. Global Platinum based Cancer Drug Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Platinum based Cancer Drug Sales by Type (2018-2024) & (US& Million)
Table 9. Global Platinum based Cancer Drug Market Share in Value by Type (2018-2024)
Table 10. Global Platinum based Cancer Drug Price by Type (2018-2024) & (USD/Unit)
Table 11. Global Platinum based Cancer Drug Sales by Type (2024-2034) & (K Units)
Table 12. Global Platinum based Cancer Drug Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Platinum based Cancer Drug Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Platinum based Cancer Drug Sales Market Share in Value by Type (2024-2034)
Table 15. Global Platinum based Cancer Drug Price by Type (2024-2034) & (USD/Unit)
Table 16. North America Platinum based Cancer Drug Sales by Type (2018-2024) & (K Units)
Table 17. North America Platinum based Cancer Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Platinum based Cancer Drug Sales (K Units) by Type (2018-2024)
Table 19. Europe Platinum based Cancer Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Platinum based Cancer Drug Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Platinum based Cancer Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Platinum based Cancer Drug Sales (K Units) by Type (2018-2024)
Table 23. Latin America Platinum based Cancer Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Platinum based Cancer Drug Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Platinum based Cancer Drug Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Platinum based Cancer Drug Sales by Company (2018-2024) & (K Units)
Table 27. Global Platinum based Cancer Drug Sales Share by Company (2018-2024)
Table 28. Global Platinum based Cancer Drug Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Platinum based Cancer Drug Revenue Share by Company (2018-2024)
Table 30. Global Market Platinum based Cancer Drug Price by Company (2018-2024) & (USD/Unit)
Table 31. Global Platinum based Cancer Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Platinum based Cancer Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Platinum based Cancer Drug as of 2022)
Table 34. Date of Key Manufacturers Enter into Platinum based Cancer Drug Market
Table 35. Key Manufacturers Platinum based Cancer Drug Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Platinum based Cancer Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Platinum based Cancer Drug Sales by Region (2018-2024) & (K Units)
Table 39. Global Platinum based Cancer Drug Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Platinum based Cancer Drug Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Platinum based Cancer Drug Sales Market Share in Value by Region (2018-2024)
Table 42. Global Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 43. Global Platinum based Cancer Drug Sales by Region (2024-2034) & (K Units)
Table 44. Global Platinum based Cancer Drug Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Platinum based Cancer Drug Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Platinum based Cancer Drug Sales Market Share in Value by Region (2024-2034)
Table 47. Global Platinum based Cancer Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 48. Global Platinum based Cancer Drug Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Platinum based Cancer Drug Sales by Application (2018-2024) & (K Units)
Table 50. Global Platinum based Cancer Drug Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Platinum based Cancer Drug Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Platinum based Cancer Drug Sales Market Share in Value by Application (2018-2024)
Table 53. Global Platinum based Cancer Drug Price by Application (2018-2024) & (USD/Unit)
Table 54. Global Platinum based Cancer Drug Sales by Application (2024-2034) & (K Units)
Table 55. Global Platinum based Cancer Drug Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Platinum based Cancer Drug Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Platinum based Cancer Drug Sales Market Share in Value by Application (2024-2034)
Table 58. Global Platinum based Cancer Drug Price by Application (2024-2034) & (USD/Unit)
Table 59. North America Platinum based Cancer Drug Sales by Application (2018-2024) (K Units)
Table 60. North America Platinum based Cancer Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Platinum based Cancer Drug Sales by Application (2018-2024) (K Units)
Table 62. Europe Platinum based Cancer Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Platinum based Cancer Drug Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Platinum based Cancer Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Platinum based Cancer Drug Sales by Application (2018-2024) (K Units)
Table 66. Latin America Platinum based Cancer Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Platinum based Cancer Drug Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Platinum based Cancer Drug Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Platinum based Cancer Drug Sales by Country (2018-2024) & (K Units)
Table 70. North America Platinum based Cancer Drug Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Platinum based Cancer Drug Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Platinum based Cancer Drug Sales Market Share in Value by Country (2018-2024)
Table 73. North America Platinum based Cancer Drug Sales by Country (2024-2034) & (K Units)
Table 74. North America Platinum based Cancer Drug Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Platinum based Cancer Drug Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Platinum based Cancer Drug Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Platinum based Cancer Drug Sales by Country (2018-2024) & (K Units)
Table 78. Europe Platinum based Cancer Drug Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Platinum based Cancer Drug Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Platinum based Cancer Drug Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Platinum based Cancer Drug Sales by Country (2024-2034) & (K Units)
Table 82. Europe Platinum based Cancer Drug Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Platinum based Cancer Drug Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Platinum based Cancer Drug Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Platinum based Cancer Drug Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Platinum based Cancer Drug Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Platinum based Cancer Drug Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Platinum based Cancer Drug Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Platinum based Cancer Drug Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Platinum based Cancer Drug Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Platinum based Cancer Drug Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Platinum based Cancer Drug Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Platinum based Cancer Drug Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Platinum based Cancer Drug Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Platinum based Cancer Drug Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Platinum based Cancer Drug Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Platinum based Cancer Drug Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Platinum based Cancer Drug Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Platinum based Cancer Drug Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Platinum based Cancer Drug Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Platinum based Cancer Drug Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Platinum based Cancer Drug Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Platinum based Cancer Drug Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Platinum based Cancer Drug Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Platinum based Cancer Drug Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Platinum based Cancer Drug Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Platinum based Cancer Drug Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Platinum based Cancer Drug Sales Market Share in Value by Country (2024-2034)
Table 109. Sanofi Company Information
Table 110. Sanofi Introduction and Business Overview
Table 111. Sanofi Platinum based Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 112. Sanofi Platinum based Cancer Drug Product
Table 113. Sanofi Recent Development
Table 114. Hengrui Medicine Company Information
Table 115. Hengrui Medicine Introduction and Business Overview
Table 116. Hengrui Medicine Platinum based Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 117. Hengrui Medicine Platinum based Cancer Drug Product
Table 118. Hengrui Medicine Recent Development
Table 119. ASK Pharma Company Information
Table 120. ASK Pharma Introduction and Business Overview
Table 121. ASK Pharma Platinum based Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 122. ASK Pharma Platinum based Cancer Drug Product
Table 123. ASK Pharma Recent Development
Table 124. Yi Bai Pharmaceutical Company Information
Table 125. Yi Bai Pharmaceutical Introduction and Business Overview
Table 126. Yi Bai Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 127. Yi Bai Pharmaceutical Platinum based Cancer Drug Product
Table 128. Yi Bai Pharmaceutical Recent Development
Table 129. Qilu Pharmaceutical Company Information
Table 130. Qilu Pharmaceutical Introduction and Business Overview
Table 131. Qilu Pharmaceutical Platinum based Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 132. Qilu Pharmaceutical Platinum based Cancer Drug Product
Table 133. Qilu Pharmaceutical Recent Development
Table 134. Teva Company Information
Table 135. Teva Introduction and Business Overview
Table 136. Teva Platinum based Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 137. Teva Platinum based Cancer Drug Product
Table 138. Teva Recent Development
Table 139. Pfizer Company Information
Table 140. Pfizer Introduction and Business Overview
Table 141. Pfizer Platinum based Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 142. Pfizer Platinum based Cancer Drug Product
Table 143. Pfizer Recent Development
Table 144. Dr Reddy's Laboratories Company Information
Table 145. Dr Reddy's Laboratories Introduction and Business Overview
Table 146. Dr Reddy's Laboratories Platinum based Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 147. Dr Reddy's Laboratories Platinum based Cancer Drug Product
Table 148. Dr Reddy's Laboratories Recent Development
Table 149. Mylan Company Information
Table 150. Mylan Introduction and Business Overview
Table 151. Mylan Platinum based Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 152. Mylan Platinum based Cancer Drug Product
Table 153. Mylan Recent Development
Table 154. Sun Pharma Company Information
Table 155. Sun Pharma Introduction and Business Overview
Table 156. Sun Pharma Platinum based Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 157. Sun Pharma Platinum based Cancer Drug Product
Table 158. Sun Pharma Recent Development
Table 159. Novartis Company Information
Table 160. Novartis Introduction and Business Overview
Table 161. Novartis Platinum based Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 162. Novartis Platinum based Cancer Drug Product
Table 163. Novartis Recent Development
Table 164. Debiopharm Company Information
Table 165. Debiopharm Introduction and Business Overview
Table 166. Debiopharm Platinum based Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 167. Debiopharm Platinum based Cancer Drug Product
Table 168. Debiopharm Recent Development
Table 169. Accord Healthcare Company Information
Table 170. Accord Healthcare Introduction and Business Overview
Table 171. Accord Healthcare Platinum based Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 172. Accord Healthcare Platinum based Cancer Drug Product
Table 173. Accord Healthcare Recent Development
Table 174. SK Chemicals Company Information
Table 175. SK Chemicals Introduction and Business Overview
Table 176. SK Chemicals Platinum based Cancer Drug Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 177. SK Chemicals Platinum based Cancer Drug Product
Table 178. SK Chemicals Recent Development
Table 179. Key Raw Materials Lists
Table 180. Raw Materials Key Suppliers Lists
Table 181. Platinum based Cancer Drug Market Trends
Table 182. Platinum based Cancer Drug Market Drivers
Table 183. Platinum based Cancer Drug Market Challenges
Table 184. Platinum based Cancer Drug Market Restraints
Table 185. Platinum based Cancer Drug Distributors List
Table 186. Platinum based Cancer Drug Downstream Customers
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Platinum based Cancer Drug Product Picture
Figure 2. Global Platinum based Cancer Drug Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Platinum based Cancer Drug Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Platinum based Cancer Drug Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Cisplatin
Figure 6. Global Cisplatin Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Oxaliplatin
Figure 8. Global Oxaliplatin Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Carboplatin
Figure 10. Global Carboplatin Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global Platinum based Cancer Drug Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Platinum based Cancer Drug Sales Market Share by Type in 2022 & 2034
Figure 15. North America Platinum based Cancer Drug Sales Market Share in Volume by Type in 2022
Figure 16. North America Platinum based Cancer Drug Sales Market Share in Value by Type in 2022
Figure 17. Europe Platinum based Cancer Drug Sales Market Share in Volume by Type in 2022
Figure 18. Europe Platinum based Cancer Drug Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Platinum based Cancer Drug Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Platinum based Cancer Drug Sales Market Share in Value by Type in 2022
Figure 21. Latin America Platinum based Cancer Drug Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Platinum based Cancer Drug Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Platinum based Cancer Drug Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Platinum based Cancer Drug Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Platinum based Cancer Drug Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Platinum based Cancer Drug Revenue in 2022
Figure 27. Platinum based Cancer Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Colorectal Cancer
Figure 29. Global Colorectal Cancer Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Ovarian Cancer
Figure 31. Global Ovarian Cancer Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Lung Cancer
Figure 33. Global Lung Cancer Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Global Platinum based Cancer Drug Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Platinum based Cancer Drug Sales Market Share by Application in 2022 & 2034
Figure 38. North America Platinum based Cancer Drug Sales Market Share in Volume by Application in 2022
Figure 39. North America Platinum based Cancer Drug Sales Market Share in Value by Application in 2022
Figure 40. Europe Platinum based Cancer Drug Sales Market Share in Volume by Application in 2022
Figure 41. Europe Platinum based Cancer Drug Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Platinum based Cancer Drug Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Platinum based Cancer Drug Sales Market Share in Value by Application in 2022
Figure 44. Latin America Platinum based Cancer Drug Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Platinum based Cancer Drug Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Platinum based Cancer Drug Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Platinum based Cancer Drug Manufacturing Cost Structure
Figure 49. Platinum based Cancer Drug Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed